Cedars-Sinai experts are advocating for patients to have access to GLP-1 medications such as semaglutide as a key component to caring for and preventing cardiovascular disease.

That’s good news for women who struggle to motivate themselves to hit the gym, says study co-author Dr. Martha Gulati, ...

Speaking about the study to Time magazine, study co-author Dr. Martha Gulati, director of preventive cardiology at Cedars-Sinai in Los Angeles, said, “For me, the news to women is: a little goes ...